JP7278281B2 - ニコチン錠 - Google Patents

ニコチン錠 Download PDF

Info

Publication number
JP7278281B2
JP7278281B2 JP2020529346A JP2020529346A JP7278281B2 JP 7278281 B2 JP7278281 B2 JP 7278281B2 JP 2020529346 A JP2020529346 A JP 2020529346A JP 2020529346 A JP2020529346 A JP 2020529346A JP 7278281 B2 JP7278281 B2 JP 7278281B2
Authority
JP
Japan
Prior art keywords
nicotine
tablet
orally disintegrating
seconds
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020529346A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505546A5 (enExample
JP2021505546A (ja
Inventor
プロフストゴール ニールセン、ブルーノ
アルビン ニールセン、ケント
Original Assignee
フェルティン ファルマ アー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=64744343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP7278281(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by フェルティン ファルマ アー／エス filed Critical フェルティン ファルマ アー／エス
Publication of JP2021505546A publication Critical patent/JP2021505546A/ja
Publication of JP2021505546A5 publication Critical patent/JP2021505546A5/ja
Application granted granted Critical
Publication of JP7278281B2 publication Critical patent/JP7278281B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020529346A 2017-12-08 2018-12-07 ニコチン錠 Active JP7278281B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201770925 2017-12-08
DKPA201770925 2017-12-08
PCT/DK2018/050335 WO2019110072A1 (en) 2017-12-08 2018-12-07 Nicotine tablet

Publications (3)

Publication Number Publication Date
JP2021505546A JP2021505546A (ja) 2021-02-18
JP2021505546A5 JP2021505546A5 (enExample) 2022-01-04
JP7278281B2 true JP7278281B2 (ja) 2023-05-19

Family

ID=64744343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020529346A Active JP7278281B2 (ja) 2017-12-08 2018-12-07 ニコチン錠

Country Status (10)

Country Link
US (3) US11738016B2 (enExample)
EP (2) EP3906916A1 (enExample)
JP (1) JP7278281B2 (enExample)
CN (1) CN111447921B (enExample)
AU (1) AU2018378648B2 (enExample)
CA (1) CA3085062C (enExample)
DK (1) DK3720418T3 (enExample)
ES (1) ES2890975T3 (enExample)
PL (1) PL3720418T3 (enExample)
WO (1) WO2019110072A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018378648B2 (en) 2017-12-08 2021-06-03 Fertin Pharma A/S Nicotine tablet
CA3085065C (en) 2017-12-08 2023-12-05 Fertin Pharma A/S Formulations providing high nicotine concentrations
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
AU2021289162A1 (en) 2020-06-08 2023-02-09 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11382861B1 (en) * 2020-12-17 2022-07-12 Nirajkumar Karneshbhai Patel Nicotine pouch
JP2024523520A (ja) 2021-06-25 2024-06-28 ニコベンチャーズ トレーディング リミテッド 経口製品及び製造方法
WO2023007440A1 (en) 2021-07-30 2023-02-02 Nicoventures Trading Limited Aerosol generating substrate comprising microcrystalline cellulose
CN113827575A (zh) * 2021-11-02 2021-12-24 上海普康药业有限公司 一种利伐沙班片剂及其制备方法
CN115969898A (zh) * 2023-02-09 2023-04-18 东莞市吉纯生物技术有限公司 一种防治口腔溃疡的口含烟含片及其制备方法
WO2025056129A1 (en) 2023-09-12 2025-03-20 Fertin Pharma A/S Orally disintegrating nicotine tablet for use under lip
EP4543417A1 (en) 2023-09-12 2025-04-30 Fertin Pharma A/S Orally disintegrating nicotine tablet for use under lip

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006518761A (ja) 2003-02-24 2006-08-17 ファーマシューティカル プロダクションズ， インコーポレイテッド 経粘膜薬物送達システム
WO2009007771A1 (en) 2007-07-06 2009-01-15 Gumlink A/S High volume compressed chewing gum tablet
JP2010526876A (ja) 2007-05-16 2010-08-05 マクニール アーベー アミノ酸によって緩衝化されたコーティング経口ニコチン製剤
JP2011519862A (ja) 2008-05-01 2011-07-14 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー ニコチンロゼンジ組成物
JP2012505878A (ja) 2008-10-14 2012-03-08 マクニール アーベー 複数部分口内剤形及びその使用
JP2014503539A (ja) 2010-12-22 2014-02-13 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性の固体被覆剤形
US20140328973A1 (en) 2011-12-22 2014-11-06 Bruno Provstgaard Nielsen Method of releasing nicotine from chewing gum
JP2015503581A (ja) 2012-01-05 2015-02-02 マクニール・アーベーＭｃＮｅｉｌＡＢ 感覚刺激性撹乱の低減された固体ニコチン含有剤形

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866046A (en) 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
EP1128817A1 (en) 1998-10-27 2001-09-05 Biovail Technologies Ltd Microparticles containing peg and/or peg glyceryl esters
US20010016593A1 (en) 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
US6583160B2 (en) * 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
US6248760B1 (en) 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
RU2003129506A (ru) * 2001-03-06 2005-03-10 Киова Хакко Когио Ко., Лтд. (Jp) Быстрораспадающаяся во рту таблетка
CA2449415A1 (en) 2001-04-20 2002-10-31 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
US20060057207A1 (en) 2001-11-30 2006-03-16 Pfizer Inc Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
SE0104388D0 (sv) 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20150080442A1 (en) 2003-02-24 2015-03-19 Pharmaceutical Productions Inc. Transmucosal drug delivery system
MXPA06000852A (es) 2003-07-24 2006-03-30 Smithkline Beecham Corp Peliculas que se disuelven oralmente.
US7387788B1 (en) * 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
WO2005055945A2 (en) * 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US20070196474A1 (en) 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
WO2007071580A1 (de) 2005-12-21 2007-06-28 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
US20070269386A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
BRPI0716995A2 (pt) 2006-09-27 2013-10-15 Niconovum Ab Métodos para administração oral de um líquido, e para aplicação de gotículas líquidas ou líquido atomizado contendo uma substância ativa no interior da boca de um indivíduo, dispositivo de pulverização, uso de um líquido, kit, e, uso de um kit
EP2101744A2 (en) * 2006-12-01 2009-09-23 Cima Labs Inc. Oral transmucosal nicotine dosage form
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
EP2177213B1 (en) 2008-09-17 2013-01-02 Siegfried Ltd. Nicotine-containing granulate
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
SE535587C2 (sv) 2011-03-29 2012-10-02 Chill Of Sweden Ab Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
TW201318650A (zh) 2011-11-02 2013-05-16 Hua Yu Wuxi Pharmaceutical Co Ltd 口崩片組成物
US11779045B2 (en) * 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
WO2016004952A1 (en) 2014-07-08 2016-01-14 Fertin Pharma A/S Oral delivery system comprising two compartments
US20170172995A1 (en) 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10610526B2 (en) 2015-12-30 2020-04-07 Next Generation Labs, LLC Nicotine replacement therapy products comprising synthetic nicotine
AU2018378648B2 (en) 2017-12-08 2021-06-03 Fertin Pharma A/S Nicotine tablet
CA3085064C (en) 2017-12-08 2023-10-24 Fertin Pharma A/S Nicotine mouth spray
CA3085065C (en) 2017-12-08 2023-12-05 Fertin Pharma A/S Formulations providing high nicotine concentrations
PL3720496T3 (pl) 2017-12-08 2025-04-28 Fertin Pharma A/S Stały doustny preparat nikotynowy
EP3720498A1 (en) 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine absorption

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006518761A (ja) 2003-02-24 2006-08-17 ファーマシューティカル プロダクションズ， インコーポレイテッド 経粘膜薬物送達システム
JP2010526876A (ja) 2007-05-16 2010-08-05 マクニール アーベー アミノ酸によって緩衝化されたコーティング経口ニコチン製剤
WO2009007771A1 (en) 2007-07-06 2009-01-15 Gumlink A/S High volume compressed chewing gum tablet
JP2011519862A (ja) 2008-05-01 2011-07-14 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー ニコチンロゼンジ組成物
US20130289079A1 (en) 2008-05-01 2013-10-31 GlaxoSmithKline, LLC Nicotine Lozenge Composition
JP2012505878A (ja) 2008-10-14 2012-03-08 マクニール アーベー 複数部分口内剤形及びその使用
JP2014503539A (ja) 2010-12-22 2014-02-13 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性の固体被覆剤形
US20140328973A1 (en) 2011-12-22 2014-11-06 Bruno Provstgaard Nielsen Method of releasing nicotine from chewing gum
JP2015503581A (ja) 2012-01-05 2015-02-02 マクニール・アーベーＭｃＮｅｉｌＡＢ 感覚刺激性撹乱の低減された固体ニコチン含有剤形

Also Published As

Publication number Publication date
CN111447921A (zh) 2020-07-24
EP3906916A1 (en) 2021-11-10
EP3720418A1 (en) 2020-10-14
PL3720418T3 (pl) 2021-12-20
AU2018378648B2 (en) 2021-06-03
DK3720418T3 (da) 2021-10-11
US11738016B2 (en) 2023-08-29
ES2890975T3 (es) 2022-01-25
CN111447921B (zh) 2023-10-13
US12433881B2 (en) 2025-10-07
AU2018378648A1 (en) 2020-07-23
US20190175581A1 (en) 2019-06-13
US20240285610A1 (en) 2024-08-29
US20230346768A1 (en) 2023-11-02
JP2021505546A (ja) 2021-02-18
EP3720418B1 (en) 2021-08-04
CA3085062A1 (en) 2019-06-13
CA3085062C (en) 2022-08-16
US12005058B2 (en) 2024-06-11
WO2019110072A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
JP7278281B2 (ja) ニコチン錠
JP7398374B2 (ja) 固形経口ニコチン製剤
CA3085066C (en) Formulations providing high nicotine concentrations
JP7574286B2 (ja) 圧縮ニコチンロゼンジ
US12115155B2 (en) Solid dosage form of a nicotine concentration
RU2786451C2 (ru) Твердый пероральный никотиновый состав
RU2831119C2 (ru) Твердый пероральный никотиновый состав
US20250082579A1 (en) Orally disintegrating nicotine tablet for use under lip
US20250082569A1 (en) Orally disintegrating nicotine tablet with low amount of flavor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230222

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230425

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230509

R150 Certificate of patent or registration of utility model

Ref document number: 7278281

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150